↓ Skip to main content

Cochrane Database of Systematic Reviews

Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia

Overview of attention for article published in Cochrane database of systematic reviews, October 2004
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
12 tweeters
weibo
1 weibo user
facebook
1 Facebook page
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
86 Mendeley
Title
Central action beta-blockers versus placebo for neuroleptic-induced acute akathisia
Published in
Cochrane database of systematic reviews, October 2004
DOI 10.1002/14651858.cd001946.pub2
Pubmed ID
Authors

Thomas RE Barnes, Karla Soares-Weiser, Josué Bacaltchuk

Abstract

Neuroleptic-induced akathisia is a common, distressing early-onset adverse effect of neuroleptic drugs. It has been associated with poor treatment compliance and an increased risk of relapse.

Twitter Demographics

The data shown below were collected from the profiles of 12 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 86 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 86 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 13 15%
Researcher 10 12%
Other 8 9%
Student > Master 8 9%
Student > Doctoral Student 5 6%
Other 20 23%
Unknown 22 26%
Readers by discipline Count As %
Medicine and Dentistry 23 27%
Psychology 9 10%
Nursing and Health Professions 6 7%
Pharmacology, Toxicology and Pharmaceutical Science 6 7%
Neuroscience 5 6%
Other 8 9%
Unknown 29 34%

Attention Score in Context

This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 July 2021.
All research outputs
#2,402,217
of 20,398,654 outputs
Outputs from Cochrane database of systematic reviews
#5,077
of 12,053 outputs
Outputs of similar age
#25,310
of 201,061 outputs
Outputs of similar age from Cochrane database of systematic reviews
#89
of 196 outputs
Altmetric has tracked 20,398,654 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,053 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.1. This one has gotten more attention than average, scoring higher than 57% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 201,061 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 196 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.